Due to an unprecedented demand from the medical community, the Cardiometabolic Health Congress (CMHC), the premier multidisciplinary congress providing the best cardiometabolic science and clinical education, has expanded its educational program and is pleased to announce the 2013 Cardiometabolic Week, October 2–5, 2013, in Boston, MA. As new treatment modalities for cardiovascular, metabolic, and related comorbidities progress from bench to bedside, the CMHC has expanded its educational initiative to continue to lead the way in translating cutting-edge science into real-world practical solutions that make a significant impact on clinical practice and patient outcomes.
The CMHC has experienced extraordinary growth—including a significant increase in participant registration, association and publication support, and demand for additional scientific sessions to cover the breadth and depth of cardiometabolic-related disorders, as well as a considerable amount of growth in corporate-supported symposia and non-CME sessions. “For the CMHC to continue to provide the much-needed expert-level education to meet the demand from the multiple specialties engaged in treating cardiometabolic disorders, we definitely outgrew our current congress format; and to accommodate such demand, adding additional time dedicated to education was imperative,” said Dina Kouveliotes, managing director of the CMHC.
“It is striking that the CMHC has become the undisputed leader in conferences that address the most important metabolic derangements of our time, due largely to the strength of the faculty and their interactions with an engaged audience,” said James Gavin III, MD, PhD, CEO, chief medical officer of Healing Our Village Inc., and clinical professor of medicine, Emory University School of Medicine.
The CMHC is supported by 32 prestigious medical societies representing multiple specialties, including the American College of Cardiology, American Heart Association, The Endocrine Society, the World Heart Federation, American Society of Bariatric Physicians, National Kidney Foundation, American Society of Hypertension, and the American Academy of Pediatrics, among many others.
The 7th Annual CMHC, featuring 59 world-renowned expert faculty, 15 scientific sessions, 14 corporate-supported and corporate-sponsored symposia, and approximately 30 CME credit hours, will convene October 10–13, 2012, in Boston, MA, and is co-chaired by George L. Bakris, MD; Christie M. Ballantyne, MD; Robert H. Eckel, MD; and Jay S. Skyler, MD, MACP. The CMHC provides the most advanced-level cardiometabolic education encompassing a multitude of risk factors, including obesity, type 2 diabetes, cardiovascular disease, dyslipidemia, atherosclerosis, hypertension, thrombosis, acute coronary syndrome, chronic kidney disease, and related comorbidities.